ChemicalBook > Product Catalog >Biochemical Engineering >Inhibitors >Epigenetics >Histone Methyltransferase Inhibitors >GSK 343

GSK 343

GSK 343 Structure
CAS No.
1346704-33-3
Chemical Name:
GSK 343
Synonyms
GSK343;CS-728;GSK 343;GSK-343;GSK343, >=98%;GSK-343/GSK343;GSK 343 USP/EP/BP;GSK343;GSK 343;GSK-343;1-Isopropyl-N-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-6-(2-(4-methylpiperazi;1-(1-Methylethyl)-N-[(6-methyl-2-oxo-4-propyl-1,2-dihydro-3-pyridinyl)methyl]-6-[2-(4-methyl-1-piper
CBNumber:
CB52666625
Molecular Formula:
C31H39N7O2
Molecular Weight:
541.69
MOL File:
1346704-33-3.mol
MSDS File:
SDS
Modify Date:
2023/6/30 15:45:59

GSK 343 Properties

Boiling point 797.4±60.0 °C(Predicted)
Density 1.26±0.1 g/cm3(Predicted)
storage temp. 2-8°C
solubility DMSO: soluble15mg/mL, clear
form powder
pka 11.84±0.10(Predicted)
color , white to beige to brown
InChIKey ULNXAWLQFZMIHX-UHFFFAOYSA-N

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS07
Signal word  Warning
Hazard statements  H302
Precautionary statements  P301+P312+P330
Hazard Codes  Xn
Risk Statements  22
WGK Germany  3
NFPA 704
0
2 0

GSK 343 price More Price(2)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich(India) SML0766 GSK343 ≥98% (HPLC) 1346704-33-3 5MG ₹14267.35 2022-06-14 Buy
Sigma-Aldrich(India) SML0766 GSK343 ≥98% (HPLC) 1346704-33-3 25MG ₹58054.48 2022-06-14 Buy
Product number Packaging Price Buy
SML0766 5MG ₹14267.35 Buy
SML0766 25MG ₹58054.48 Buy

GSK 343 Chemical Properties,Uses,Production

Uses

GSK343 has been used:

  • as an inhibitor of?enhancer of zeste homolog 2 (EZH2) to assess the impact of chromatin condensation on?cell migration
  • as histone methyl transferase inhibitor, to suppress the Polyandrocarpa misakiensis, mitochondrial non-coding-region (NCR) PmNCR?reporter gene expression, facilitated?by TC14-3
  • as a supplement in the growth medium to inhibit the generation of H3K27me3 or to inhibit RNA polymerase II
  • as EZH2 inhibitor to treat castration-resistant neuroendocrine prostate cancer (CRPC-NE)

Biochem/physiol Actions

GSK343 is a potent, specific inhibitor of the histone H3-lysine 27 (H3K27) methyltransferase EZH2. GSK343 inhibits EZH2 enzymatic activity with an IC50 of 4 nM. The compound displays 60 fold selectivity for EZH2 vs. EZH1, and 1000 fold or greater selectivity against other histone methyltransferases. The IC50 for inhibition of H3K27 methylation is < 200 nM in HCC1806 cells. For full characterization details, please visit the GSK343 probe summary on the Structural Genomics Consortium (SGC) website.To learn about other SGC chemical probes for epigenetic targets, visit sigma.com/sgc

GSK 343 Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 144)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
A.J Chemicals 91-9810153283 New Delhi, India 6124 58 Inquiry
ATK CHEMICAL COMPANY LIMITED +undefined-21-51877795 China 32760 60 Inquiry
career henan chemical co +86-0371-86658258 +8613203830695 China 29826 58 Inquiry
Shanghai Daeyeon Chemicals Co., Ltd 021-64478606 +8615900664856 China 2062 58 Inquiry
Dideu Industries Group Limited +86-29-89586680 +86-15129568250 China 24639 58 Inquiry
Zhejiang J&C Biological Technology Co.,Limited +1-2135480471 +1-2135480471 China 10522 58 Inquiry
Henan Alfa Chemical Co., Ltd +8618339805032 China 13187 58 Inquiry
InvivoChem +1-708-310-1919 +1-13798911105 United States 6393 58 Inquiry
TargetMol Chemicals Inc. +1-781-999-5354 United States 19973 58 Inquiry
ShenZhen Trendseen Biological Technology Co.,Ltd. 13417589054 China 11681 58 Inquiry

GSK 343 Spectrum

1H-Indazole-4-carboxamide, N-[(1,2-dihydro-6-methyl-2-oxo-4-propyl-3-pyridinyl)methyl]-1-(1-methylethyl)-6-[2-(4-methyl-1-piperazinyl)-4-pyridinyl]- 1-(1-Methylethyl)-N-[(6-methyl-2-oxo-4-propyl-1,2-dihydro-3-pyridinyl)methyl]-6-[2-(4-methyl-1-piperazinyl)-4-pyridinyl]-1H-indazole-4-carboxamide GSK343 GSK 343 GSK343 GSK-343 GSK-343/GSK343 1-(1-Methylethyl)-N-[(6-Methyl-2-oxo-4-propyl-1,2-dihydro-3-pyridinyl)Methyl]-6-[2-(4-Methyl-1-piperazinyl)-4-pyridinyl]-1H-indazole-4-carboxaMide N-[(1,2-Dihydro-6-methyl-2-oxo-4-propyl-3-pyridinyl)methyl]-1-(1-methylethyl)-6-[2-(4-methyl-1-piperazinyl)-4-py N-[(1,2-Dihydro-6-methyl-2-oxo-4-propyl-3-pyridinyl)methyl]-1-(1-methylethyl)-6-[2-(4-methyl-1-piperazinyl)-4-pyridinyl]-1H-indazole-4-carboxamide N-[(6-Methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl]-6-[2-(4-methylpiperazin-1-yl)pyridin-4-yl]-1-(propan-2-yl)-1H- GSK343, >=98% 1-Isopropyl-N-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-6-(2-(4-methylpiperazi GSK 343 USP/EP/BP CS-728 1-isopropyl-n-[(6-methyl-2-oxo-4-propyl-1,2-dihydro-3-pyridinyl)m Ethyl]-6-[2-(4-methyl-1-piperazinyl)-4-pyridinyl]-1h-indazole-4-c Arboxamide GSK343;GSK 343;GSK-343 N-((2-hydroxy-6-methyl-4-propylpyridin-3-yl)methyl)-1-isopropyl-6-(2-(4-methylpiperazin-1-yl)pyridin-4-yl)-1H-indazole-4-carboxamide N-[(6-METHYL-2-OXO-4-PROPYL-1H-PYRIDIN-3-YL)METHYL]-6-[2-(4-METHYLPIPERAZIN-1-YL)PYRIDIN-4-YL]-1-PROPAN-2-YLINDAZOLE-4-CARBOXAMIDE 1-Isopropyl-N-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-6-(2-(4-methylpiperazin-1-yl)pyridin-4-yl)-1H-indazole-4-carboxamide 1-(1-Methylethyl)-N-[(6-methyl-2-oxo-4-propyl-1,2-dihydro-3-pyridinyl)methyl]-6-[2-(4-methyl-1-piper 1346704-33-3 C31H39N7O2 API Inhibitors